NASDAQ Partners Accretive
The NASDAQ OMX Group Inc. (NDAQ), entered into a partnership with an innovator in fixed income securities indexing, Accretive Asset Management LLC. The liaison is dedicated to the BulletShares Corporate Bond Index family of Accretive. In a joint effort, NASDAQ OMX and Accretive will endorse the BulletShares concept all over the world.
Accretive Asset Management produces investment products that aid financial Advisors to provide better service to their clients. It developed the BulletShares method in 2009 to merge the benefits of individual bonds and bond funds. As of May 29, 2013, Accretive had licensed BulletShares Indices to 14 ETFs with assets worth nearly $2.5 billion under license.
NASDAQ now intends to tap this credibility of Accretive and utilize its expertise, powerful brand name and marketing knowledge to expand the NASDAQ BulletShares Index. The NASDAQ BulletShares Index indicates how an investment is performing in a diversified, held-to-maturity portfolio of fixed income securities with a common maturity period.
With maturity dates spanning from 2013 to 2022, there are 20 indexes in total, including high yield and corporate bond indexes. As per the agreement, the indexes are now co-branded under NASDAQ and BulletShares. Additional plans for new versions are in progress.
Through the expansion of BulletShares brand globally, the deal is expected to invite more investors for the indexes. We expect this to help NASDAQ to gain on top line results and thereby earnings. Once the company starts to reap the benefits, earnings is likely to exceed our present projection of $2.66 per share for full year 2013, which translates into a year-over-year improvement of 6.20%.
Towards its business expansion objective, NASDAQ included a leading Internet television network – Netflix Inc (NFLX) to its Global Index group in Jun, 2013.
NASDAQ currently carries a Zacks Rank #3 (Hold). Among others, CBOE Holdings Inc. (CBOE) and MarketAxess Holdings Inc. (MKTX) carry a favorable Zacks Rank #2 (Buy) and appear impressive.
Read the Full Research Report on NDAQ
Read the Full Research Report on NFLX
Read the Full Research Report on CBOE
Read the Full Research Report on MKTX
More From Zacks.com
